45-mg hydrocodone bitartrate extended-release tablet (crushed or intact)
C33237/1085
Phase 1 small_molecule completed
Quick answer
45-mg hydrocodone bitartrate extended-release tablet (crushed or intact) for Drug Abuse is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Drug Abuse
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed